The pharma industry is exploring new sales and marketing models to meet modern, multifaceted challenges. Historically, CSOs have provided a flexible, cost-effective means for pharma to adjust. However, given the current state of flux, just how relevant can CSOs be in helping pharma manage such major change?
Ashfield, assisted by Dr Beth Rogers, has investigated this issue with 16 senior sales and buying professionals from pharma companies across Europe. Dr Beth Rogers is the author of Rethinking Sales Management and several papers on the outsourcing of sales functions.